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Abstract
A rather new and somewhat unusual concept connects brain functions to gut microbiota. 
It is called “gut-brain axis” (or “microbiota-gut-brain axis”) and states that probiotics 
consumption and a healthy gut microbiota positively influence brain functions related 
to behavior and cognition. Synergistic with a low chronic grade peripheral inflamma-
tion, this faulty barrier exposes the aged brain to negative extra-cerebral signals. Given 
the quasi-constant failure of pharmacological treatments in neurodegenerative diseases, 
increased interest is directed toward allopathic medicine, including dietary supplements. 
Interplay between gut microbiota and central nervous system by immune, neural and 
metabolic pathways is being explored as a possible modulator of cognitive impairment 
and behavior disorders. In elderly persons, this axis has been reported to be altered, con-
tributing to systemic inflammation and was also indicated as a possible marker for early 
frailty in younger population. Currently, there are several clinical trials addressing the 
relationship between gut microbiota and central nervous system psychiatric disorders 
and at least one directly investigating whether there is a correlation between composi-
tion of gut microbiome, permeability of intestinal barrier and systemic inflammation in 
patients with dementia. This chapter discusses evidence-based data on positive modula-
tion of gut-brain axis to alleviate behavior and cognition alterations in the elderly.
Keywords: nutraceuticals, gut-brain axis, microbiota, inflammaging, aging, 
neurodegeneration, anxiolytic
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1. Introduction
In recent years, great progress has been made in characterizing bidirectional interactions 
between central nervous system (CNS), enteric nervous system and gastrointestinal tract. 
Dr Michael Gershon has defined the gut as “the second brain” [1] for several reasons: the 
enteric nervous system may function autonomously (it is capable of reflexes in the absence of 
CNS input), it can communicate with CNS through the parasympathetic (via vagal nerve) and 
sympathetic (via paravertebral ganglia) nervous system and is susceptible to neurotrophic 
and neuromodulators signaling.
The term gut-brain axis is often extended to include the role of intestinal flora in the system, 
in which case the axis is called microbiota-gut-brain axis. The microbiota is not limited to bac-
teria but also includes protozoa, fungi, nematodes and viruses, so that in the intestinal tract 
there are over 1000 species of bacteria out of a total of approximately 100 trillion organisms 
[2]. To maintain the homeostasis of such complex system, permanent correlation between the 
gut and the brain is essential.
The gastrointestinal microbiota has a symbiotic relationship with enteric cells and contributes 
to basic physiological processes such as digestion, growth and immune defense. The com-
position of an individual’s microbiota depends on the mode of delivery at birth, genetic pre-
disposition, age, nutrition, physical activity, environmental factors, stress, infections, other 
diseases and the use of antibiotics [3].
Gut microbiota can influence the functioning of the CNS by the ability to synthesize 
or mimic some molecules such as host-signaling neuroactive molecules, for example, 
acetylcholine, catecholamine, g-aminobutyric acid (GABA), histamine, melatonin and 
serotonin [4]. Conversely, the composition of the microbiota is influenced by emotional 
and psychological stress [5], resulting, for example, in the decrease in Lactobacilli spe-
cies or the increase of Clostridium species [6, 7]. Although communication between the 
components of the microbiota-gut-brain axis has been well established by preclinical 
and clinical studies (excellently reviewed in [8–11]), the exact mechanisms by which 
this communication is made remains largely unknown. The interest in this research area 
began to consistently grow since the early 2000s, when one of the first papers to be pub-
lished showed that germ-free (GF) mice exhibit an exaggerated hypothalamus-pituitary 
axis (HPA) response to stress compared to a normal mouse [12]. These results were later 
on confirmed by other studies on rodents grown in a germ-free (GF) environment that 
showed how gut microbiota influences the development of emotional behavior, stress 
and pain systems modulation, and the functioning of neurotransmitter systems in the 
brain [13, 14]. This communication between gut and brain was proven to be dependent 
on at least two elements such as vagus nerve signaling and specific bacterial species 
[15–18]. Further on, the influence of gut microbiota composition on high cognitive pro-
cesses and brain chemistry [19] was demonstrated by its modulation with probiotics and 
antibiotics [10, 20].
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Studies on GF mice also highlighted another surprising relationship between gut microbiota 
and aging and in the occurrence of aging-related-diseases. It has been shown that GF mice 
live significantly longer than normal animals, probably due to the reduction of pathological 
infections, with a first report back in the mid 1960s [21], followed by others in mice [22, 23] 
Drosophila melanogaster [24], Caernohabditis elegans [25].
We shall further detail some topics related to the gut-brain axis in the elderly, like gut-brain 
alterations observed in preclinical and clinical studies, some data about neuro-nutraceu-
ticals with a focus on mechanisms and gut-brain axis modulation with a final reference to 
clinical trials.
2. Evidence-based data of gut-brain axis alteration in aged laboratory 
animals
Aging is (so far) an irreversible process which impacts on all cell populations, with several 
common denominators such as genomic instability, epigenetic alterations and oxidative stress 
[26]. It equally affects gut lining and brain cells, but it also changes the gut microbiota com-
position [27, 28] which in turn is associated with behavioral and physiological modifications. 
An anxious behavioral phenotype was observed while transferring fecal microbiota between 
two strains of mice [10]. Also, fecal microbiota transplantation from depressed patients to 
microbiota-depleted rats may have the potential to provoke behavioral and physiological 
features specific to depression, including anhedonia, anxiety-like behaviors, as well as modi-
fications in tryptophan metabolism, suggesting that gut microbiota could be an important 
player in neurobehavioral changes in the rat [29]. Reduced anxiety and depression-related 
comportment in mice were connected to dysregulated GABA signaling by metabolizing 
dietary glutamate through certain strains of Lactobacillus and Bifidobacteria [30]. Another study 
focused on the analysis of microbiota of aged mice. It is reported that, although composition 
differed significantly, there was only an insignificant overall increase in bacterial taxa, from 
that of young mice. At phylum level, the most common microbial taxa were Bacteroidetes 
and Firmicutes. A few statistically significant differences in bacterial groups were noticed 
in aged mice. At the phylum level, TM7 was significantly higher, while at family level abun-
dance less than 1%, significant increases in Porphyromondaceae, TM7 uncultured, Clostridiaceae, 
Thermoanaerobacteraceae, Desulfovibrionaceae and Oxalobacteraceae were seen in aged mice com-
pared to young. Genera Odoribacter was much higher in the aged group whereas, other bacte-
rial genera, including Butyricimonas, TM7 uncultured, Gelria, Anaerosporobacter, Clostridium 
and Oxalobacter had significant increases in aged mice. The Chao 1 index (which estimates 
species richness), the number of observed species and the phylogenetic diversity, the Shannon 
Index (alpha diversity) and beta diversity were higher in the aged compared with young 
groups. Also, gut permeability in young and aged mice prior to and after 1 h of restraint stress 
was assessed, proved that aged mice had significantly greater basal intestinal permeability 
than young mice [31].
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3. Evidence of gut-brain axis alteration in old patients
Each human organism hosts a widely diverse population of microbes that form a “metaorgan-
ism” (comprising 10 bacterial cells for every one of our own) [32]. This metaorganism, which is 
now studied thoroughly in major scientific endeavors such as Human Microbiome Project [33], 
impacts on its host as much as the human host changes it back throughout different life stages. 
Microbial diversity and intestinal microflora stability decrease with age [27, 28] and are accom-
panied by a reduction in brain function and a decrease in cognitive abilities [34, 35]. Furthermore, 
alteration of gut microbiota homeostasis, through dietary or environmental factors, can lead to 
an imbalance between symbionts and pathobionts, resulting in reduced intestinal barrier func-
tion such as a dysbiosis state can be related to subsequent metabolic and inflammatory disor-
ders, visceral pain and even alterations in brain functioning [36]. Other studies have shown 
that while the microbial composition of the gut changes with age, it is not a linear process. The 
two dominant phyla in younger persons, Bacteroides and Firmicutes, remain prominent at older 
ages, but there are supposed to be changes in the percentage of these phyla, a fact still under 
discussion. Other studies support the prevalence of potentially pathogenic bacteria (e.g. proteo-
bacteria) that are detrimental for symbiotic beneficial bacteria (e.g. species of Bifidobacteria) [37]. 
In this regard, there is an increased interest in the putative role of microbial gut in the fragility 
and vulnerability associated with the aging process.
Gut microbiota and extreme longevity are the main topics of several interesting studies. There 
are evidence that extreme aging might be supported by subdominant gut microbiota spe-
cies, along with pro-inflammatory species and health-associated taxa [38]. Another study 
was focused on long-lived Chinese people and gut microbiota, with a special reference to 
the above-mentioned study. Significant differences in community membership and structures 
between the Italian and Chinese long-living groups were observed, attributed to many factors 
such as geography, genetics, diets and DNA-extraction methods [39].
These findings emphasize the importance of sampling a healthy population, both in terms 
of age, geographic and cultural traditions in order to identify features of gut microbiomes 
signatures related to age [40].
Age-associated alterations in gut microbiota are associated with subsequent decline with 
age in the functionality of the immune system (immunosenescence) and a chronic low-
grade inflammatory status, partially due to increased intestinal permeability and increased 
colonic cytokine expression (inflammaging) [41]. The inflammaging process can undermine 
the homeostatic equilibrium and accelerate the changes in gut microbiota structure and 
composition that could be related to the progression of diseases and frailty in the elderly 
population [42].
Mabbott et al. in 2015 [43] provided an important advance in our understanding on the effects 
of aging on intestinal permeability and innate mucosal immune responsiveness in elderly 
patients. Using human terminal ileal biopsy tissues, they demonstrated that intestinal permea-
bility to solutes, but not macromolecules, was significantly increased in the intestines of elderly 
humans. Tran and Greenwood-Van Meerveld in 2013 [44] showed for the first time a pivotal 
contributing factor to geriatric vulnerability to gastrointestinal dysfunction may increase colonic 
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 permeability via age-associated remodeling of intestinal epithelial tight  junction  proteins. 
On the opposite side is a recent report by Valentini et al. that found no correlation between 
aging and increased intestinal permeability (or altered intestinal barrier), but mentioned low-
grade inflammation as a possible favoring factor [45].
Age-related physiological modifications in the gastrointestinal tract undoubtedly affect the 
gut microbiota and high susceptibility to infections becomes an inevitable consequence. The 
gut microbiota homeostasis seem to play a crucial role for the gut well-being during the aging 
process and, in this perspective, dietary control of the gut microbiota of the elderly could be 
an important target for preserving a healthy gut microbiota community [42].
4. Neuro-nutraceuticals: definition, examples and mechanisms of 
action
Nutraceuticals are defined as “food or food product that provides medical or health benefits includ-
ing the prevention and treatment of diseases” [46]. This concept is partially overlapping with 
the term “bioactive compounds” – “secondary plant metabolites eliciting pharmacological 
or toxicological effects in man and animals” [47]. Neuro-nutraceuticals are, by extrapolation, 
active compounds, obtained from food products or plants that exert effects on the CNS. They 
can be represented by vitamins, amino acids, minerals, trace elements, etc., with presumed 
health-promoting or disease-preventing effects. Oxidative stress, dysregulation of redox met-
als homeostasis and inflammation represent the main leading causes of brain aging and there-
fore the administration of antioxidant and anti-inflammatory molecules can be an important 
strategy for preventing brain aging and several brain age-related diseases such as Parkinson’s 
disease, Alzheimer’s disease, dementia and depression [48, 49].
However, the evaluation of nutraceutical efficacy and safety represents a big challenge due to 
the complex chemical compositions and multiple mode of actions [50]. Starting from chemi-
cal classification of bioactive compounds [47], several classes have been repeatedly associated 
with beneficial neurological effects. Flavonoids consist of a central three-ring structure and may 
occur as oligomers -proanthocyanidins. All compounds contain phenol groups with antioxi-
dant effect. Many different polyphenols have been reported to retard age-related declines in 
CNS function, cognition and behavior. A polyphenol with the ability to modulate a multitude 
of signaling molecules and with antibacterial, anti-inflammatory and neuroprotective proper-
ties is curcumin, the active ingredient in the spice turmeric. Curcumin acting as an antioxidant, 
anti-inflammatory and lipophilic agent can improve the cognitive functions in animal models 
and patients with Alzheimer’s disease by several mechanisms. Short-term supplementation of 
curcumin to aged rats enhanced the frequency of polysialylated cells in the dentate infragran-
ular zone and significantly improved both spatial learning and memory in adult and aged 
rats [51]. The long-term curcumin-supplemented diet had a important effects on hippocampal 
cellular proliferation, cognitive function and transcriptional responses in aged rats and this 
response is dependent of the length of curcumin treatment [52]. Curcumin administration 
supported the immune system to reduce beta-amyloid plaques, ensures the delayed degrada-
tion of neurons and decreased microglia activation resulting in the improvement of overall 
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memory [53]. Curcumin treatment could also improve the outcome of patients with traumatic 
brain injury by reducing acute activation of microglia/macrophages and neuronal apoptosis, 
demonstrated by in vivo experiments [54]. Eugenol (4-allyl-2-methoxyphenol), an antioxidant 
and anti-inflammatory molecule, found in various plants such as basil, cinnamon and other 
herbs is another nutraceutical with demonstrated roles in brain physiology. In the Drosophila 
model, eugenol manifests neuroprotective effects in acrylamide-induced neuropathy models. 
In vitro studies showed that eugenol enhanced the viability of neuroblastoma cell lines by 
reducing oxidative stress in experimental hyperglycemia. Moreover in diabetic rats, eugenol 
administration results in reduction of oxidative markers in brain with restoration of activi-
ties of mitochondrial complexes I, II and III [55, 56]. Other polyphenols (anthocyanin extract, 
pomegranate or resveratrol), exerted their anti-inflammatory effects by reducing TNF-a brain 
level and microgliosis or sirtuin activation in correlation with improving brain plasticity in 
non-transgenic AD animal models [57, 58]. Resveratrol positive effects were also related to 
the activation of AMP-activated kinase (AMPK) and the antioxidant transcription factorNrf2 
(nuclear factor (erythroid derived 2)-like 2) [59]. In a randomized, double-blind, placebo-
controlled, phase II trial of resveratrol for patients with Alzheimer’s disease, resveratrol was 
detected in cerebrospinal fluid with beneficial effects such as the alteration of Alzheimer’s dis-
ease biomarker trajectories, the preservation of blood-brain barrier integrity and the modula-
tion of the central nervous system immune response [60].
Methylxanthine alkaloids (found in coffee and cocoa) elicit stimulating neurological effects. Some 
tropane alkaloids are analgesics [61]. Aromatic compounds, terpenes/terpenoids and aliphatic mol-
ecules, particularly with low molecular weights, found in plant essential oils, were mentioned as 
free radicals scavengers and acetylcholine esterase inhibitors [62]. Some volatile oils were associ-
ated with anxiolytic and antidepressant effects, along with strong antioxidant effects [63].
Creatine is a nitrogenous organic acid found in animal tissues being involved in several crit-
ical processes in the brain such as the sustaining of energy supply, antioxidant processes 
and neuroprotection. Increased dietary intake of creatine can elevate brain creatine levels 
which can sustain cognitive function under oxidative and nitrosative stress. Several in vitro 
or even preclinical studies showed that creatine directly preserves mitochondrial function in 
adult neurodegenerative conditions [64, 65]. Clearly, mitochondrial impairment contributes 
directly and/or indirectly to the pathogenesis of numerous neurodegenerative disorders [66]. 
Exogenous creatine supplementation reduced neuronal cell loss in acute and chronic neuro-
logical diseases and promoted differentiation of neuronal precursor cells [67]. In vivo studies 
showed that maternal creatine supplementation during pregnancy protects the brain against 
the effects of severe birth asphyxia [68, 69].
A special class of food derivatives or food ingredients includes prebiotics and probiotics.
Prebiotics are defined as “nondigestible food ingredients that beneficially affect the host by 
selectively stimulating the growth or the activity of one or a limited number of bacteria 
(Bifidobacteria and Lactobacilli) in the colon” [70]. From chemical perspective, they are fruc-
tooligosaccharides, enzymatically processed in the colon with positive impact on commensal 
flora. Fermentation of prebiotics generates short-chain fatty acids [71], which exert positive 
effects on integrity of epithelial barrier, but also on brain metabolism, as discussed later.
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Probiotics are “viable microorganisms, sufficient amounts of which reach the intestine in an 
active state and thus exert positive health effects” [72]. The most commonly used probiotics 
are bacterial species (frequently, Lactobacillus and Bifidobacterium, but also some E. coli and 
Bacillus species), but the yeast Saccharomyces cerevisiae and can also be employed [73].
Both types of nutraceuticals exert positive effects beyond local, intestinal environment. 
Prebiotics were demonstrated to exhibit triglycerides and cholesterol-lowering effects [70], 
with beneficial effect on blood-brain barrier integrity and brain lipid metabolism. Among 
many local effects, it is worth mentioning that, related to gut-brain axis, probiotics modify the 
gut microbiota, which is the main determinant of tryptophan levels, the serotonin precursor, 
hence the documented effect of these food supplements as anxiety alleviators.
Throughout the next sections, some evidence of modulation of gut-brain axis with nutraceuti-
cals in the elderly will be discussed, in relationship with experimental results from preclinical 
and clinical studies.
5. Modulation of gut-brain axis with nutraceuticals in the elderly: 
evidence-based benefits in animal models
Diet and altered gut physiology, together with age-related changes in intestinal microbiome and 
a weakened immune system [74, 75] result in low-grade inflammation in the gut, that is associ-
ated with systemic release of pro-inflammatory metabolites. Finally, the inflammatory process is 
related to glial cells activation, neuroinflammation and to cognitive decline in the elderly [37, 41].
A useful model for the study of gut-brain axis is the germ-free (GF) mouse. GF mice have socially 
impaired behavior [12] and present an exaggerated stress response [76] that can be directly cor-
related with changes occurring in different regions of the brain [13], depressed neurogenesis 
[77] and prefrontal cortical hypermyelination [78]. However, preclinical studies reveal that oral 
administration of probiotics and/or nutraceuticals is sufficient to reduce anxiety-like and depres-
sive-like behaviors and to induce changes in brain chemistry [10, 79]. For example, the impaired 
microglial function in GF animals was rescued by the oral treatment with short-chain fatty acids 
[80]. Also, Distrutti et al. [81], showed that a probiotic mixture (VSL#3) induced a significant 
change in the composition of gut microbiota of aged rats and increased brain tissue expression 
of genes associated with inflammation and neural plasticity such as BDNF and synapsin.
The gut microbiome is also essential to the bioavailability of polyphenols, unsaturated fats and 
antioxidants, all of which may help protect against neuronal and cell aging under normal cir-
cumstances [82]. For example, the diet supplemented with blueberries (rich in anthocyanin 
and flavanols) improved spatial working memory in aged animals [83]. This process is accom-
panied by increases in neural stem cells proliferation, extracellular receptor kinase activation 
and increase of insulin-like growth factor-1 (IGF-1) level, the key modulator of hippocampal 
neurogenesis [84]. Also, aged rats consuming berry diets exhibited enhanced motor perfor-
mance and improved cognition, correlated with increased hippocampal neurogenesis and 
expression of IGF-1 [85].
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Since short-chain fatty acids (SCFA) seem to play an important role in shaping the gut micro-
biota metabolism, it was necessary to study the effect of omega-3 polyunsaturated acids (n-3 
PUFA) on cognitive decline in aging. Animal studies have shed light on their neuroprotec-
tive roles through pathways of synaptic plasticity, neuroinflammation and oxidative stress, 
evidencing also positive correlations between peripheral n-3 PUFA levels and regional gray 
matter [86]. Supplementation of n-3 PUFA increased hippocampal neurogenesis and the fatty 
acid docosahexaenoic acid (DHA—an intermediate molecule in the metabolism of eicosapen-
taenoic acid) was able to down regulate microglial activation [87]. Furthermore, age-related 
decline in c-Fos expression, that reflects neuronal response to extracellular signals such as 
growth factors and is triggered during action potentials, is attenuated by n-3 PUFA diet [88]. 
The protective role of n-3 PUFA supplementation in counteracting cognitive decline, emo-
tional dysfunctions and brain atrophy is governed by antioxidant and anti-inflammatory 
mechanisms [86, 89]. Some evidence in animal models suggested that long-term consumption 
of fish oil (rich in n-3 PUFA) may predispose the brain to lipid oxidation. The enrichment of 
fish oil with quercetin significantly attenuated behavioral impairments, restored the ROT-
induced oxidative markers, depleted dopamine levels in striatum and reduced mitochondrial 
dysfunction, offering a higher neuroprotection in animal model [90].
Phytosterols, a class of nutraceuticals derivated from plant foods, have been demonstrated to 
possess cholesterol-lowering, antioxidant effects and recently neuroprotective role on cogni-
tive deficit induced by a cholesterol-enriched diet in aged rats. The phytosterol ester (PSE) 
treatment maintained the body weight balance, reduced serum lipid levels and improved the 
cognitive performance of aged rats in the Morris water maze test. Importantly, histological 
and immunohistochemical results in the brain showed that PSE supplementation alleviates 
neuroinflammation by significantly increasing the number of pyramidal cells and decreas-
ing the number of astrocytes. Furthermore, PSE improved cholinergic activities by restoring 
the acetylcholine (ACh) content and decreasing acetylcholinesterase (AChE) activity in the 
cerebral cortex, as well as by elevating choline acetyl transferase (ChAT) activity in the hip-
pocampus and the cerebral cortex [91].
In conclusion, preclinical studies support the rationale of further clinical testing of nutritional 
strategies to improve aged brain function, including the use of bioactive compounds with 
antioxidant, anti-inflammatory or neuroprotective properties in the diet of the elderly.
6. Neuro-nutraceuticals/gut-brain axis targeting in clinical trials
The direct modulation of gut microbiome by targeted dietary and probiotic uptake seem to 
have a positive impact in treating particular age-related disorders and represent a promising 
therapeutic option for the aging process itself [28]. Well supported evidence came from find-
ings from ELDERMET, a research consortium (http://eldermet.ucc.ie) which studied and char-
acterized the gut microbiota in an Irish elderly population anti its relationship to mental health 
in aging [92]. As a consequence of a growing body of evidence regarding a positive correlation 
between the health of gut microbiota and brain health, funding for clinical research is also spent 
for study of modulation of gut-brain axis with impact on healthy aging and mental health.
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No. Clinical trial Main objective Status Reference
1 Microbiome and the gut-brain axis To examine the relationship 
between digestive tract microbes 
and mental health
Completed https://clinicaltrials.gov/
ct2/show/NCT02693327
2 Microbiome and dementia To study the role of gut 
microbiome composition and gut 
permeability in the progression of 
dementia
Recruiting https://clinicaltrials.gov/
ct2/show/NCT03167983
3 Full4Health: understanding 
food-gut-brain axis across the life 
course
To examine how dietary 
manipulation influences the 
relationship between hunger/
satiety/food preference and gut 
hormones, neural activation and 
energy metabolism
Completed https://clinicaltrials.gov/
ct2/show/NCT01597024
4 Oral fecal transplant in cirrhosis To evaluate the safety and 
tolerability of oral fecal transplant 
in patients with cirrhosis and 
hepatic encephalopathy
Recruiting https://clinicaltrials.gov/
ct2/show/NCT03152188
5 Reduced appetite in Crohn’s 
disease: the role of the brain in the 
control of food intake
To investigate the changes in 
activity in areas of the brain that 
control food intake
Recruiting https://clinicaltrials.gov/
ct2/show/NCT02772458
6 FMT treating constipation patients 
with depression and/or anxiety 
symptoms - clinical efficacy and 
potential mechanisms
To observe the clinical efficiency 
of fecal microbiota transplant and 
the role of the gut microbiome in 
treating patients with constipation, 
depression and/or anxiety
Recruiting https://clinicaltrials.gov/
ct2/show/NCT03233100
7 Prebiotic intake reduces the 
waking cortisol response
and alters emotional bias in 
healthy volunteers
To investigate the effects of two 
prebiotics on the secretion of 
cortisol and emotional response in 
healthy individuals
Completed [93]
8 A randomized, double-blind, 
placebo-controlled pilot study of a 
probiotic in emotional symptoms 
of chronic fatigue syndrome
To study how the administration 
of Lactobacillus casei strain Shirota 
affects the mood of patients with 
chronic fatigue syndrome
Completed [94]
9 Assessment of psychotropic-
like properties of a probiotic 
formulation (Lactobacillus helveticus 
R0052 and Bifidobacterium longum 
R0175) in rats and human subjects
To study the effects of probiotic 
formulations on stress, anxiety, 
depression and coping strategies 
in healthy volunteers
Completed [95]
10 A randomized controlled trial 
to test the effect of multispecies 
probiotics on cognitive reactivity 
to sad mood
To evaluate whether a multispecies 
probiotic formulation can reduce 
cognitive reactivity in non-
depressed individuals
Completed [96]
11 Metabolic effect of new foods 
through gut-brain axis
To measure the effectiveness 
of coffee melanoidins, bread 
melanoidins, beta-glucans and 
a Gentiana lutea L. extract in 
decreasing energy intake and 
modifying the physiological 
markers of satiety in the short term
Recruiting https://clinicaltrialbase.
com/study/NCT01851304/
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Clinical trials targeting not only the cross-talk between the gut microbiota and the central 
nervous system focus on its association with various neuropsychiatric and neurodegenerative 
disorders (anxiety, depression, dementia, etc.), but also on its involvement in the regulation 
of hunger/satiety and in pathologies affecting the digestive tract (Table 1). The therapeutic 
solutions investigated these clinical trials involve the use of prebiotics and probiotics, dietary 
changes and fecal microbiota transplant.
Reports of already completed trials support the findings of preclinical trials, demonstrating 
that modulation of gut microbiota results in anxiolytic effect without a direct intervention 
on neurotransmitter circuitries. For example, the reported results of Schmidt et al. [93], after 
completion of trial, supported previous evidence that fructooligosaccharides, or Bimuno®-
galactooligosaccharides supplementation lowered neuroendocrine stress response, measured 
by cortisol awakening response. Rao et al. [94] reported that supplementation with specific 
lactic acid probiotic bacteria for 8 weeks improved the anxiety scores of patients with chronic 
fatigue syndrome. A complex report by Messaoudi et al. [95], involving both laboratory rats 
as well as healthy human volunteers showed that supplementation with a combination of 
Lactobacillus helveticus and Bifidobacterium longum displayed beneficial psychological effect. 
Finally, a recent publication regarding the effect of “4-week multispecies probiotics interven-
tion showed a significantly reduced overall cognitive reactivity to sad mood”, [96]. These 
results open a promising avenue not only for age-related mental disorders, but also for selected 
cases of psychiatric pathologies.
7. Conclusions
Gut-brain axis is a bidirectional chemical network sending information between the intestine and 
the brain via soluble, chemical messages as well as nervous sympathetic and  parasympathetic 
No. Clinical trial Main objective Status Reference
12 FMT for patients with IBS with 
fecal and mucosal microbiota 
assessment
To assess the efficiency of fecal 
microbiota transplant in treating 
irritable bowel syndrome
Recruiting https://clinicaltrialbase.
com/study/NCT03125564/
13 Effects of green-MED diet via the 
gut-fat-brain axis
To investigate the effect of 
a Mediterranean diet low in 
processed meat on the gut 
microbiota and age-related 
declines (changes in adiposity, 
cognitive function and 
cardiometabolic risk)
Recruiting https://clinicaltrialbase.
com/study/NCT03020186/
14 The clinical research on the 
relationship between circadian 
rhythm and gut microbiota in TBI 
patients
To examine whether the gut 
microbiota is involved in the 
modulation of sleep disorders 
in patients with brain traumatic 
injury
Recruiting https://clinicaltrialbase.
com/study/NCT02849028/
Table 1. Clinical trials related to investigation of gut-brain axis in relationship with mental health.
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inputs. A third player with a determinant role in the health of both systems is the gut micro-
biota. Aging affects all players of the microbiota-gut-brain axis, leading to modified com-
position of bacterial taxa, chronic low-grade inflammation, modified intestinal metabolism, 
resulting in diminished availability of neurotransmitters or neurotransmitter precursors and 
short-chain fatty acids. Along with synaptic impairment, oxidative stress and neuroinflam-
mation, aging leads to behavior alterations, anxiety and cognitive impairment. Interventions 
on gut-brain axis with nutraceuticals (food or food-derived products that have putative bene-
ficial effects) alleviate some age-associated behavioral and cognitive alterations, as repeatedly 
demonstrated in animal models. Recently, clinical trials have begun to explore the beneficial 
effect of gut-brain axis modulation, in mood or cognition-associated disorders. Upon reports 
of positive results, gut-brain axis emerges as an important, easy to access target for promoting 
a healthy brain aging.
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